Search research articles
Contact Us
Filters
Showing results (71-80 of 94) with videos related to
Page
of 10
Sort By:
Medicina
|
January 1, 1982
Detection of intermediate density lipoproteins in the plasma of diabetic patients
R L de Wikinski, L Henao, C Rivas Figueroa, et al.
The Journal of Biological Chemistry
|
October 4, 1996
Dissociation of phospholamban regulation of cardiac sarcoplasmic reticulum Ca2+ATPase by quercetin
E McKenna, J S Smith, K E Coll, et al.
Clinical Science (London, England : 1979)
|
April 1, 1991
Doxepin therapy for postprandial symptomatic hypoglycaemic patients: neurochemical, hormonal and metabolic disturbances
F Lechin, B van der Dijs, A Lechin, et al.
Nefrologia : Publicacion Oficial De La Sociedad Espanola Nefrologia
|
June 2, 2010
[Prevalence of cardiovascular disease in uraemia and relevance of cardiovascular risk factors]
S Collado, E Coll, R Deulofeu, et al.
Medicina Intensiva
|
October 30, 2016
End-of-life practices in patients with devastating brain injury in Spain: implications for organ donation
B Domínguez-Gil, E Coll, T Pont, et al.
Bioorganic & Medicinal Chemistry Letters
|
May 6, 2003
2,4-disubstituted pyrimidines: a novel class of KDR kinase inhibitors
Peter J Manley, Adrienne E Balitza, Mark T Bilodeau, et al.
Vaccine
|
April 27, 2010
Safety, tolerability, and immunogenicity of zoster vaccine in subjects with a history of herpes zoster
Richard Mills, Stephen K Tyring, Myron J Levin, et al.
Anales De Pediatria (Barcelona, Spain : 2003)
|
March 18, 2008
[SEN1500: design and implementation of a registry of infants weighing less than 1,500 g at birth in Spain]
M Moro Serrano, C Fernández Pérez, J Figueras Alloy, et al.
Vaccine
|
May 13, 2015
Safety, tolerability, and immunogenicity of zoster vaccine in subjects on chronic/maintenance corticosteroids
Amy F Russell, Janie Parrino, Chester L Fisher, et al.
Current Medicinal Chemistry
|
March 23, 2004
Property-based design of KDR kinase inhibitors
Mark E Fraley, William F Hoffman, Kenneth L Arrington, et al.
Page
of 10
Search research articles
Search
Showing results (71-80 of 94) with videos related to
Sort By:
Page
of 10
Medicina
|
January 1, 1982
Detection of intermediate density lipoproteins in the plasma of diabetic patients
R L de Wikinski, L Henao, C Rivas Figueroa, et al.
The Journal of Biological Chemistry
|
October 4, 1996
Dissociation of phospholamban regulation of cardiac sarcoplasmic reticulum Ca2+ATPase by quercetin
E McKenna, J S Smith, K E Coll, et al.
Clinical Science (London, England : 1979)
|
April 1, 1991
Doxepin therapy for postprandial symptomatic hypoglycaemic patients: neurochemical, hormonal and metabolic disturbances
F Lechin, B van der Dijs, A Lechin, et al.
Nefrologia : Publicacion Oficial De La Sociedad Espanola Nefrologia
|
June 2, 2010
[Prevalence of cardiovascular disease in uraemia and relevance of cardiovascular risk factors]
S Collado, E Coll, R Deulofeu, et al.
Medicina Intensiva
|
October 30, 2016
End-of-life practices in patients with devastating brain injury in Spain: implications for organ donation
B Domínguez-Gil, E Coll, T Pont, et al.
Bioorganic & Medicinal Chemistry Letters
|
May 6, 2003
2,4-disubstituted pyrimidines: a novel class of KDR kinase inhibitors
Peter J Manley, Adrienne E Balitza, Mark T Bilodeau, et al.
Vaccine
|
April 27, 2010
Safety, tolerability, and immunogenicity of zoster vaccine in subjects with a history of herpes zoster
Richard Mills, Stephen K Tyring, Myron J Levin, et al.
Anales De Pediatria (Barcelona, Spain : 2003)
|
March 18, 2008
[SEN1500: design and implementation of a registry of infants weighing less than 1,500 g at birth in Spain]
M Moro Serrano, C Fernández Pérez, J Figueras Alloy, et al.
Vaccine
|
May 13, 2015
Safety, tolerability, and immunogenicity of zoster vaccine in subjects on chronic/maintenance corticosteroids
Amy F Russell, Janie Parrino, Chester L Fisher, et al.
Current Medicinal Chemistry
|
March 23, 2004
Property-based design of KDR kinase inhibitors
Mark E Fraley, William F Hoffman, Kenneth L Arrington, et al.
Page
of 10